Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

RDY Dr Reddy's Laboratories Ltd

52.220
-0.070-0.13%
Close 09/29 16:00 ET
52.2200.0000.00%
Post Mkt Price 09/29 16:00 ET
High
52.920
Open
52.810
Turnover
20.48M
Low
52.160
Pre Close
52.290
Volume
390.92K
Market Cap
8.67B
P/E(TTM)
23.08
52wk High
66.435
Shares
165.98M
P/E(Static)
27.93
52wk Low
47.194
Float Cap
6.10B
Bid/Ask %
50.00%
Historical High
73.747
Shs Float
116.91M
Volume Ratio
1.20
Historical Low
3.665
Dividend TTM
0.316
Div Yield TTM
0.329
P/B
3.45
Dividend LFY
0.61%
Div Yield LFY
0.63%
Turnover Ratio
0.33%
Amplitude
1.45%
Avg Price
52.379
Lot Size
1
Float Cap
6.10B
Bid/Ask %
50.00%
Historical High
73.747
Shs Float
116.91M
Volume Ratio
1.20
Historical Low
3.665
Dividend TTM
0.316
P/B
3.45
Dividend LFY
0.61%
Turnover Ratio
0.33%
Amplitude
1.45%
Avg Price
52.379
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
CEO: Mr. Erez Israeli
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...